My Nonprofit Reviews

Compassion, deft therapeutic skill, and up-to-the-minute theoretical models mesh to save troubled youth who are beyond at-risk, and bring them back to life after being abandoned by families, harassed by peers, and zoned-out on anti-psychotic medication. It gets so exhilarating to see these youngsters begin to thrive by rising to the skillfully-curated challenges of the High Sierra environment where lockdown and even the latest drugs had failed them.

Doug Robinson
Alpine Guide and Neurochemist

MAPS is a refreshing island of curiosity in a sea of prejudice. The prejudice is obvious, surrounding us from the legions of "Just say No" to the pharmacological sloppiness that classes psychedelics with entirely different realms of compounds like the opioids. Objectively, that's just plain ignorant and would not be worth commenting on except that it confuses so many and leads to bad laws. MAPS is sponsoring the leading push toward new scientific information about useful drugs that are trapped behind this societal prejudice. For instance, they sponsored the first FDA-approved study of the effectiveness of MDMA ("Ecstasy") as an adjunct to psychotherapy for intractable cases of Post Traumatic Stress Syndrome. The results, not yet published, are spectacular! Follow-up studies are now planned or underway in Spain, Israel, and Switzerland. Several other psychedelic compounds are to be studied in similarly rigorous ways in US government approved protocols in the near future. None of this vital and fresh information would be possible without the outstanding effort of MAPS. Push back the darkness. The Dark Ages of these useful compounds are nearly over!

More Feedback